We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Rules For Elan In Naproxen Patent Suit

Law360 (May 11, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has reversed a lower court’s decision to invalidate drug maker Elan's patent for controlled-release naproxen.

The appeals court found that the U.S....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.